Literature DB >> 22127432

Will the BEAT-ROP study results really beat ROP?

Seemant Raizada, Jamal Al Kandari, Khalid Al Sabti.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22127432     DOI: 10.1167/iovs.11-8479

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  5 in total

1.  Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions.

Authors:  Ai-Yi Zhou; Yu-Jing Bai; Min Zhao; Wen-Zhen Yu; Lv-Zhen Huang; Xiao-Xin Li
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

2.  Posterior pole sparing laser photocoagulation combined with intravitreal bevacizumab injection in posterior retinopathy of prematurity.

Authors:  Rebecca Kim; Yu Cheol Kim
Journal:  J Ophthalmol       Date:  2014-12-28       Impact factor: 1.909

3.  The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units.

Authors:  Yunxia Leng; Wenzhi Huang; Guoliang Ren; Cheng Cai; Qingbiao Tan; Yuqin Liang; Weizhong Yang; Zongyin Gao
Journal:  BMC Ophthalmol       Date:  2018-11-20       Impact factor: 2.209

4.  Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; Zhihong Yang; Yanchao Jiang; M Elizabeth Hartnett
Journal:  Mol Vis       Date:  2014-03-03       Impact factor: 2.367

5.  SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.

Authors:  Melissa V R Gammons; Andrew D Dick; Steven J Harper; David O Bates
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-27       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.